A post-hoc subgroup analysis showed a trend of a reducing ALSFRS-R slope decline in patients with moderately severe disease progression [ 276 ].
← all excerpts
Glial Cells-The Strategic Targets in Amyotrophic Lateral Sclerosis Treatment.
1
—
—
A post-hoc subgroup analysis showed a trend of a reducing ALSFRS-R slope decline in patients with moderately severe disease progression [ 276 ].